Disruption of vanS by IS1216V in a clinical isolate of Enterococcus faecium with VanA glycopeptide resistance.
Darini
A L
AL
Palepou
M F
MF
James
D
D
Woodford
N
N
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics; D019729:Carbon-Oxygen Ligases / Q000235:genetics; D004251:DNA Transposable Elements / Q000235:genetics*; D004352:Drug Resistance, Microbial / Q000235:genetics; D016984:Enterococcus faecium / Q000187:drug effects / Q000235:genetics*; D006020:Glycopeptides; D006801:Humans; D016254:Mutagenesis, Insertional; D011494:Protein Kinases / Q000235:genetics*; D014157:Transcription Factors / Q000235:genetics*
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D004251:DNA Transposable Elements; D006020:Glycopeptides; D014157:Transcription Factors; C071437:VanA ligase, Bacteria; C073901:VanS protein, Enterococcus; D011494:Protein Kinases; D019729:Carbon-Oxygen Ligases